Sera Prognostics (SERA) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Sera Prognostics (SERA) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn | -54.61% |
| 10 | Sera Prognostics | 103.03 Mn | 103.03 Mn | -28,000.00 | 88.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 88.98% |
| Dec 31, 2025 | -59,194.24% |
| Sep 30, 2025 | 95.61% |
| Jun 30, 2025 | 94.81% |
| Mar 31, 2025 | 0.77% |
| Dec 31, 2024 | -171.00% |
| Sep 30, 2024 | -4.94% |
| Jun 30, 2024 | 93.02% |
| Mar 31, 2024 | 92.07% |
| Dec 31, 2023 | 103.67% |
| Sep 30, 2023 | 90.22% |
| Jun 30, 2023 | -952.31% |
| Mar 31, 2023 | -769.25% |
| Dec 31, 2022 | 90.77% |
| Sep 30, 2022 | -2,377.04% |
| Jun 30, 2022 | -102.11% |
| Mar 31, 2022 | -1,626.48% |
| Dec 31, 2021 | -73,403.14% |
| Sep 30, 2021 | -96.83% |
| Jun 30, 2021 | 36,306.73% |